The investigators modelled VHL-associated tumorigenesis using mice in which Vhlh in hepatocytes is conditionally inactivated by Cre–loxP recombination resulting in the formation of liver haemangiomas. Inactivation of
Hif1a
in these mice has little effect on the development of the haemangiomas, whereas livers lacking both Hif2a (also known as
Epas1
) and Vhlh were microscopically and macroscopically similar to those of control animals, suggesting that HIF2 is necessary for tumour development in this context. Moreover, the authors showed by real-time PCR that expression of vascular endothelial growth factor (Vegf), one of the angiogenic growth factors associated with VHL tumours, was suppressed by inactivation of HIF2 but not inactivation of HIF1.
Rankin and colleagues went on to investigate other HIF-related changes in gene expression by cDNA microarray and gene-ontology analysis, using Albumin–Cre transgenic mice that had Vhlh and one or both of the HIF isoforms inactivated. They found 17 other HIF-regulated angiogenic genes, of which 12 were upregulated in livers lacking VHLH or both VHLH and HIF1α, and demonstrated that this upregulation is suppressed more efficiently by inactivation of HIF2α than by inactivation of HIF1α. The presence of HIF2 was associated with increased expression of the angiogenic genes Bmp4, Klf5, Nr2f2, Angpt13, Anxa2 and Cdh5, but it is yet unclear whether this is attributable to transcriptional regulation by HIF2 or due to increased angiogenesis. However, the effect of HIF2 on gene expression was shown to be context-dependent, as no changes in expression were observed in liver for HIF2 targets that are associated with VHL tumours in other tissue types.
This is a preview of subscription content, access via your institution